Lithuania vs Panama: Access to anti-retroviral drugs, female
Lithuania
56.0%
in 2024
Panama
55.0%
in 2024
Lithuania rank
110th
Panama rank
111th
Access to anti-retroviral drugs, female over time
- Lithuania
- Panama
How they compare
Lithuania currently reports 56.0% against 55.0% in Panama, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Panama ahead.
Lithuania ranks 110th and Panama ranks 111th of 141 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 16.9% | 14.6% | Panama |
| 2010s | 20.7% | 40.8% | 20.1% | Panama |
| 2020s | 45.8% | 50.0% | 4.2% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Lithuania or Panama?
- Lithuania, at 56.0% against 55.0% in Panama as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Lithuania and Panama?
- 1.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Lithuania and Panama rank globally for access to anti-retroviral drugs, female?
- Lithuania ranks 110th and Panama ranks 111th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.